<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gerber JE</submitter><funding>NHGRI NIH HHS</funding><funding>National Human Genome Research Institute</funding><pagination>2999-3015</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8381829</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(9)</volume><pubmed_abstract>&lt;b>Objective&lt;/b>: We characterize public values regarding vaccinomics, which aims to improve vaccine safety and effectiveness using genomics.&lt;b>Methods:&lt;/b> Panel survey (2020) of ≥18-year-olds with embedded animation introduced vaccinomics. Sociodemographic, health, and vaccination-related items were adapted from validated scales. Novel items measured trust in public health authorities, vaccinomics-related values, and preferences for federal funding: vaccinomics compared with vaccine issues and chronic diseases. Beginning and end of survey confidence in vaccine safety was measured to assess potential changes. Data were weighted to the U.S. Census. Vaccinomics-related concerns were stratified by sociodemographic characteristics, vaccine hesitancy status (composite outcome), reported seriou</pubmed_abstract><journal>Human vaccines &amp; immunotherapeutics</journal><pubmed_title>Vaccinomics: a cross-sectional survey of public values.</pubmed_title><pmcid>PMC8381829</pmcid><funding_grant_id>RM1 HG009038</funding_grant_id><pubmed_authors>Brewer J</pubmed_authors><pubmed_authors>Blunt M</pubmed_authors><pubmed_authors>Carleton B</pubmed_authors><pubmed_authors>Kahn J</pubmed_authors><pubmed_authors>Gerber JE</pubmed_authors><pubmed_authors>Geller G</pubmed_authors><pubmed_authors>Limaye RJ</pubmed_authors><pubmed_authors>Sutherland A</pubmed_authors><pubmed_authors>Holroyd TA</pubmed_authors><pubmed_authors>Salmon DA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Vaccinomics: a cross-sectional survey of public values.</name><description>&lt;b>Objective&lt;/b>: We characterize public values regarding vaccinomics, which aims to improve vaccine safety and effectiveness using genomics.&lt;b>Methods:&lt;/b> Panel survey (2020) of ≥18-year-olds with embedded animation introduced vaccinomics. Sociodemographic, health, and vaccination-related items were adapted from validated scales. Novel items measured trust in public health authorities, vaccinomics-related values, and preferences for federal funding: vaccinomics compared with vaccine issues and chronic diseases. Beginning and end of survey confidence in vaccine safety was measured to assess potential changes. Data were weighted to the U.S. Census. Vaccinomics-related concerns were stratified by sociodemographic characteristics, vaccine hesitancy status (composite outcome), reported seriou</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2026-06-04T04:32:17.017Z</modification><creation>2025-05-29T19:19:16.388Z</creation></dates><accession>S-EPMC8381829</accession><cross_references><pubmed>34152932</pubmed><doi>10.1080/21645515.2021.1911217</doi></cross_references></HashMap>